Market Overview

Ampio Pharmaceuticals 8-K Indicates FDA Said In Response Letter That It Does Not Consider AP-0003-C Trial To Be Adequate And Well-Controlled Clinical Trial And Recommended Co. Performs Randomized Trial With Concurrent Trial; Shares Down 54.7% After Hours


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: Biotech News FDA Movers Trading Ideas General


Related Articles (AMPE)

Earnings Scheduled For August 8, 2018

Emblem Releasing Cannabis-Based Oral Spray This Year, That's Just The Beginning